Search results | hospital

Reports

Hospital Care Partnering Terms and Agreements

The Hospital Care artnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter hospital care partnering deals.

Insights

Fresenius: Hospital, i.v. drugs and acquisition experts

Fresenius is a large pharmaceutical company developing pharmaceutical products and medical devices for critically care and chronically ill patients. ‘Caring for life’ is the motto behind the company’s worldwide success and commitment to patient care.

Sanofi inks pharma partnering ties with Massachusetts General Hospital for oncology research

Sanofi announced a two-year pharma partnering agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors

Regenerative Medicine deal trends article

The field of regenerative medicine is an up and coming new approach of targeting and treating diseases, it involves the repair and restoration of previously damaged tissues or organs in the body. The regenerative medicine market was worth $16bn in 2013 and industry analysts predict that this will leap to over $60bn by 2020. The more »

Bioinformatics: recent life science partnering trend analysis

The bioinformatics partnering deal trend analysis 2009 to 2014 are reviewed in this article.

Arbor Pharma looking for an acquisition and merger partner

Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.

Pharma and biotech clinical stage partnering – recent trends 2009 to 2014

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials

AstraZeneca and Pfizer in the news for another possible m&a bid

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer.

Cubist Pharma, the next acquisition target for big pharmaceuticals

The timing may be right for a takeover of Cubist Pharmaceuticals.

SciClone Pharmaceuticals: Your marketing partner for China

Sciclone Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing products to treat oncology, infectious diseases and urology.

Life Science M&A Deal Trends in Q2, 2014

By Steve Poile                                     With 110 deals announced, the second quarter continued on from the strong start for life science M&A during 2014.

Events

Sorry, your search returned no results.


Deals

Janssen signs a biotech deal with Ruijin Hospital

Janssen Pharma signed a biotech deal to collaborate on translational research with Shanghai Ruijin Hospital, which opened a Translational Medicine Center in early October.

Boehringer Ingelheim pharma partners Brigham and Women’s Hospital

Boehringer Ingelheim announced a multi-year pharma partners agreement with Brigham and Women’s Hospital.

Shire & Children’s Hospital Boston enter pharma partners agreement

Irish drug giant Shire plc, will pay Boston Children’s Hospital an undisclosed amount under a three-year research pharma partners agreement intended to find new candidates to treat a range of rare pediatric diseases. This pharma partners agreement intends to fulfill the goal of developing novel therapies to treat a number of rare pediatric diseases with more »

Sanofi inks pharma partnering ties with Massachusetts General Hospital for oncology research

Sanofi announced a two-year pharma partnering agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors

Private notes placement financing for Universal Hospital Services

In a financing venture, Universal Hospital Services intends to offer up to $425 million in aggregate principal amount of second lien senior secured notes.

Big pharma Sanofi pharma partners with Brigham & Women’s Hospital for diabetes research

Sanofi, a big pharma giant announced a new research pharma partners collaboration with Brigham and Women’s Hospital focused on immunology of type 1 diabetes.

Akorn acquires three hospital-based branded injectables from Lundbeck

Oak Pharmaceuticals has acquired three off-patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck.

Children’s Hospital Boston and Pfizer enter into novel collaborative research agreement for muscular dystrophy

Childrens Hospital Boston and Pfizer have launched a new collaborative program aimed at identifying potential drug therapies for Duchenne muscular dystrophy (DMD).

MorphoSys and Daiichi Sankyo forge alliance to develop novel antibody therapies against hospital-acquired infections

MorphoSys and Daiichi Sankyo will collaboratively apply HuCAL PLATINUM, the latest and most powerful version of MorphoSys’s antibody libraries.

BioAlliance Pharma signs co-promotion agreement with Lundbeck for in-hospital prescription of Seroplex

BioAlliance Pharma will co-promote Seroplex® to its core healthcare partners (notably oncologists, radiotherapists and hematologists) as part of a comprehensive approach to patient management in general and cancer therapy in particular, in line with France’s national guidelines for cancer patients.